| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 52 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | Lee Yuchun | Director | Sale+OE | 2,000 | $284.23 | $568,466.64 | -16.9% | +1.1% | +14.9% | |
| Apr 14, 2022 | Lee Yuchun | Director | Sale+OE | 2,000 | $289.06 | $578,116.60 | -17.0% | +0.3% | +15.8% | |
| Apr 13, 2022 | Leiden Jeffrey M47 | Executive Chairman | Sell | 15,789 | $289.04 | $4,563,652.56 | -17.6% | -0.3% | +14.6% | |
| Apr 13, 2022 | Lee Yuchun | Director | Sale+OE | 4,000 | $284.27 | $1,137,060.12 | -10.7% | -0.3% | +14.6% | |
| Apr 11, 2022 | Lee Yuchun | Director | Sale+OE | 4,000 | $279.43 | $1,117,739.88 | -18.6% | +4.6% | +15.6% | |
| Apr 8, 2022 | McGlynn Margaret G51 | Director | Sale+OE | 5,000 | $280.22 | $1,401,080.00 | -68.5% | +5.0% | +15.3% | |
| Apr 8, 2022 | Bhatia Sangeeta N.48 | Director | Sale+OE | 1,907 | $280.20 | $534,341.40 | -26.9% | +5.0% | +15.3% | |
| Apr 7, 2022 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 561 | $276.18 | $154,934.97 | -0.4% | +5.6% | +16.6% | |
| Apr 7, 2022 | Lee Yuchun | Director | Sale+OE | 4,000 | $273.24 | $1,092,963.88 | -14.2% | +5.6% | +16.6% | |
| Apr 5, 2022 | Lee Yuchun | Director | Sale+OE | 4,000 | $270.11 | $1,080,423.57 | -13.5% | +7.0% | +19.3% |